Zacks lists USD 4.50 target for Cosmos Health stock

Published on 10/20/2026 at 20:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cosmos Health expects USD 15.00 million U.S. revenue for Q4 2026. Cosmos Health stock costs EUR 0.30 on October 20, 2026 at 8:13 p.m. CEST.

Analyst target and operating outlook

Zacks lists one USD 4.50 target for Cosmos Health stock.
Cosmos Health expects USD 15.00 million in fourth-quarter U.S. revenue.
Cosmos Health stock costs EUR 0.30 at Lang & Schwarz on October 20, 2026 at 8:13 p.m. CEST.
Market capitalization stood at USD 34.0 million on October 20, 2026.

COSM, US2214133058, Illustration mit AI erstellt.

One analyst target stands at USD 4.50 for Cosmos Health, while the company expects USD 15.00 million in fourth-quarter U.S. revenue. Zacks lists one short-term price target for the Nasdaq-listed healthcare company. Cosmos Health stock was trading at EUR 0.30 at Lang & Schwarz on October 20, 2026 at 8:13 p.m. CEST.

U.S. revenue guide reaches USD 15.00 million

In a release dated October 19, 2026, Cosmos Health said its U.S. direct-to-consumer business is expected to generate USD 15.00 million in fourth-quarter revenue and USD 10.50 million in gross profit. The company expects a gross margin of 70.00 percent for that business. StockTitan reported that the outlook includes USD 11.50 million from subscriptions and USD 3.50 million from one-time purchases.

The revenue guide is forward-looking rather than a reported quarterly result. The release said subscriptions were expected to provide more than three-quarters of U.S. fourth-quarter revenue, making renewals an important operating measure for the plan.

Subscriptions provide the operating measure

Active U.S. subscriptions reached 8,940 on October 19, 2026, up 42.00 percent from 6,287 five days earlier, according to StockTitan. The platform also tracked 14,624 U.S. online checkout orders, up 34.00 percent from 10,881 over the same period. Those figures are preliminary platform metrics, not revenue recognized under U.S. GAAP.

A separate Yahoo Finance article dated October 14, 2026 said 6,287 active subscriptions were already generating a monthly value of USD 920,000 at standard renewal pricing. The figure is an operating metric, so retention and cancellations remain important to the eventual revenue outcome.

Market value and analyst target

Cosmos Health had a market capitalization of USD 34.0 million on October 20, 2026. The USD 4.50 target listed by Zacks is materially above the USD 0.34 Nasdaq quote at the time of the structured market snapshot, but the target is supplied by one analyst and is not a company forecast.

The company's next reporting date has been estimated by external calendars, while its own investor-relations page did not provide a dated schedule. The next concrete operating milestones are therefore the conversion of subscription growth into recognized revenue and the delivery of the fourth-quarter U.S. outlook.

Stock price after hours

The euro quotation places Cosmos Health at EUR 0.30 at Lang & Schwarz on October 20, 2026 at 8:13 p.m. CEST. The quote is an after-hours indication for German investors, while the home listing is Nasdaq in USD.

The further course of trading is shown by the continuously updated real-time quote of Cosmos Health stock.